Zobrazeno 1 - 10
of 18
pro vyhledávání: '"Ann C. Hewkin"'
Autor:
Ann C. Hewkin, Kaffa Fakouhi, Mark E. Molitch, George L. Bakris, Pantelis Sarafidis, Peter Bacher, Mark Kipnes, James R. Sowers
Publikováno v:
Diabetes Care. 29:2592-2597
OBJECTIVE—We sought to test the hypothesis that a fixed-dose combination of trandolapril/verapamil-SR (T/V) is superior to a fixed-dose combination of losartan/hydrochlorothiazide (L/H) on glucose tolerance in hypertensive patients with impaired gl
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::7f3a6454c3a02984fc35ab6351830641
https://doi.org/10.2337/dc06-1373
https://doi.org/10.2337/dc06-1373
Publikováno v:
Diabetes, Obesity and Metabolism. 8:206-213
Background: Early weight loss is generally considered to predict long-term weight outcome in obese patients, and this is reflected in prescribing guidelines for antiobesity drugs. For example, the current prescribing guidelines for the antiobesity dr
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d96cfa258bc347bcfcbd084bb00d777b
https://doi.org/10.1111/j.1463-1326.2005.00481.x
https://doi.org/10.1111/j.1463-1326.2005.00481.x
Autor:
Efrain Gaxiola, Franz H. Messerli, David Garcia-Barreto, Ann C. Hewkin, Carl J. Pepine, Giuseppe Mancia, Eileen M. Handberg, Rhonda M. Cooper-DeHoff, Jose L. Cangiano, Peter R. Kowey, Jerome D. Cohen
Publikováno v:
Clinical Cardiology. 27:571-576
Background: Despite a high prevalence of hypertension in the population with CAD, there are limited data describing the clinical characteristics and treatments, as well as their interrelations in these patients. This is particularly true for black an
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::aa69d91ed56535d7d0d086ea924c25b3
https://doi.org/10.1002/clc.4960271010
https://doi.org/10.1002/clc.4960271010
Autor:
Julia K. Walch, Dennis M. Styne, Lisa Harris, Ann C. Hewkin, Barbara Long, Olga Jasinsky, Vicky A. Blakesley, Stephen R. Daniels, Scott J. Crow, Melinda S. Sothern, Kristine M. Cwik, Ileana Vargas-Rodriguez
Publikováno v:
Pediatrics. 120(1)
BACKGROUND. Adolescent obesity is a major public health problem. Treatment options in addition to behavioral therapy could include pharmacotherapy with sibutramine. OBJECTIVES. Concerns regarding increases in blood pressure and heart rate after sibut
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3fee2b0738df3938e2344601eb5c24b1
https://pubmed.ncbi.nlm.nih.gov/17908786
https://pubmed.ncbi.nlm.nih.gov/17908786
Autor:
Madelyn H. Fernstrom, Julia K. Walch, Ann C. Hewkin, Caroline M. Apovian, Louis J. Aronne, David Heber, Arthur Frank, Kristine M. Cwik, Vicky A. Blakesley, Frank L. Greenway, Robert F. Kushner, James L. Early
Publikováno v:
Obesity (Silver Spring, Md.). 15(6)
Objective: Our objective was to assess the efficacy and safety of sibutramine with a low-calorie diet (LCD) and commercial meal-replacement product in achieving weight loss and weight-loss maintenance in obese patients. Research Methods and Procedure
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1bf259a3f17facaa10140260e2cf3a85
https://pubmed.ncbi.nlm.nih.gov/17557984
https://pubmed.ncbi.nlm.nih.gov/17557984
Publikováno v:
J Clin Hypertens (Greenwich)
To understand the effects of single- and multiple-drug combinations for hypertension on the risk of adverse clinical outcomes, the authors analyzed data from the International Verapamil SR/Trandolapril Study (INVEST). This trial randomized 22,576 hyp
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::989c94835024bde608d6f99325a31fc4
https://europepmc.org/articles/PMC8109302/
https://europepmc.org/articles/PMC8109302/
Autor:
Serap Erdine, Jerome D. Cohen, George L. Bakris, Rhonda M. Cooper-DeHoff, Carl J. Pepine, Ann C. Hewkin, Franz H. Messerli, Stuart Kupfer
Publikováno v:
The American journal of cardiology. 98(7)
Knowledge of predictors of diabetes mellitus (DM) development in patients with coronary artery disease (CAD) who use antihypertensive therapy could contribute to decreasing this adverse metabolic consequence. This is particularly relevant because the
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3ecd526071453bfaf56a38950334e367
https://pubmed.ncbi.nlm.nih.gov/16996868
https://pubmed.ncbi.nlm.nih.gov/16996868
Autor:
C. Richard Conti, Efrain Gaxiola, David Garcia-Barreto, Jose L. Cangiano, Juan M. Aranda, Ann C. Hewkin, Rhonda M. Cooper-DeHoff, Carl J. Pepine
Publikováno v:
American heart journal. 151(5)
Background People of Hispanic origin are the fastest growing ethnic minority in the United States and often have hypertension and other comorbidities which increase the risk associated with coronary artery disease (CAD). Methods and Results An analys
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2dbb316d3df627f0b650c67d8946e90e
https://pubmed.ncbi.nlm.nih.gov/16644338
https://pubmed.ncbi.nlm.nih.gov/16644338
Autor:
Rhonda M, Cooper-DeHoff, Eileen M, Handberg, Jerome, Cohen, Peter, Kowey, Franz H, Messerli, Giuseppe, Mancia, Jose L, Cangiano, Efrain, Gaxiola, David, Garcia-Barreto, Ann C, Hewkin, Carl J, Pepine
Publikováno v:
Clinical cardiology. 27(10)
Background: Despite a high prevalence of hypertension in the population with CAD, there are limited data describing the clinical characteristics and treatments, as well as their interrelations in these patients. This is particularly true for black an
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::04136c66ff4100bd2afbfb5253379f9f
https://pubmed.ncbi.nlm.nih.gov/15553310
https://pubmed.ncbi.nlm.nih.gov/15553310
Autor:
Brigitte Kalsch, Zigmunt P Sadowski, Thomas Meinertz, Fedrico Lombardi, Ann C. Hewkin, Siegfried Eberle, Anne Camez, Gregory Y.H. Lip
Publikováno v:
The American journal of cardiology. 90(12)
We report a double-blind, multicenter, multinational, placebo-controlled, and well-controlled trial to prove that the sustained-release (SR) formulation of propafenone is superior to placebo in preventing symptoms of paroxysmal atrial fibrillation (A
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::9ccc8a9d7b46b70ad1114165338b0e2f
https://pubmed.ncbi.nlm.nih.gov/12480038
https://pubmed.ncbi.nlm.nih.gov/12480038